- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib for ovarian cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 8, Pages 1049-1062
Publisher
Informa Healthcare
Online
2013-05-15
DOI
10.1517/13543784.2013.802769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study of intermittent sorafenib with bevacizumab in bevacizumab-naive epithelial ovarian cancer (EOC) patients.
- (2017) E. C. Kohn et al. JOURNAL OF CLINICAL ONCOLOGY
- AURELIA: A randomized phase III trial evaluating bevacizumab (BEV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC).
- (2017) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian Cancer, Version 3.2012
- (2017) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies
- (2013) Munmun Rahman et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Major clinical research advances in gynecologic cancer in 2012
- (2013) Dong Hoon Suh et al. Journal of Gynecologic Oncology
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Sorafenib in melanoma
- (2012) Joanna Mangana et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sorafenib for the treatment of renal cancer
- (2012) Dirk Strumberg EXPERT OPINION ON PHARMACOTHERAPY
- Sorafenib in liver cancer
- (2012) Hyun Young Woo et al. EXPERT OPINION ON PHARMACOTHERAPY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
- (2012) Keith T. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin
- (2012) Masashi Takano et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
- (2011) Lubomir Bodnar et al. GYNECOLOGIC ONCOLOGY
- Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group
- (2011) R. Ramasubbaiah et al. GYNECOLOGIC ONCOLOGY
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases
- (2011) Masashi Takano et al. International Journal of Clinical Oncology
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raf kinases in cancer–roles and therapeutic opportunities
- (2011) G Maurer et al. ONCOGENE
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) N. Colombo et al. ANNALS OF ONCOLOGY
- Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity
- (2010) J-M Lee et al. BRITISH JOURNAL OF CANCER
- Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
- (2010) Martin Pölcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
- (2010) Noriomi Matsumura et al. CANCER SCIENCE
- Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer
- (2010) Stephen A. Welch et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
- (2010) Daniela Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- Review: Practical considerations in ovarian cancer chemotherapy
- (2010) Mihaela Cristea et al. Therapeutic Advances in Medical Oncology
- Emerging roles for Rab family GTPases in human cancer
- (2009) Wan Jie Chia et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Fertility preservation in young women with epithelial ovarian cancer
- (2009) Jason D. Wright et al. CANCER
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
- (2009) Axel Hauschild et al. JOURNAL OF CLINICAL ONCOLOGY
- Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
- (2008) Nilofer S. Azad et al. CANCER
- Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
- (2008) Robert E. Bristow et al. GYNECOLOGIC ONCOLOGY
- Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma
- (2008) J.A. RAUH-HAIN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity
- (2008) Nilofer S. Azad et al. JOURNAL OF CLINICAL ONCOLOGY
- Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors
- (2008) L. Dal Lago et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started